Contact us today to discuss your preclinical needs. Our team delivers tailored solutions, transparent timelines, and competitive pricing to keep your pipeline moving forward.
Preclinical CRO Services for Global Drug Development
At HuaTeng Biotechnology, we empower pharmaceutical and biotech innovators with comprehensive preclinical CRO services designed to streamline drug development from concept to IND submission. Our state-of-the-art facilities, globally compliant protocols, and deep scientific expertise ensure reliable data, faster timelines, and reduced risks for your preclinical programs.
Myocardial infarction (pig), diabetes (NHP), stroke (dog), and more.
Xenograft tumors, Alzheimer’s (transgenic mice), and inflammation.
Caco-2 permeability, CYP induction/inhibition, metabolite profiling.
Full PK/PD profiling in rodents, rabbits, and non-human primates.
Dose-range finding and safety margin analysis.
Acute/Chronic Toxicity
Genotoxicity, Carcinogenicity
Cardiovascular (hERG) & Respiratory Safety
Biomarker-Driven Risk Mitigation
Full-Service Expertise: Efficacy, pharmacokinetics (PK/PD), and safety studies under one roof
Globally Accredited Labs: GLP-compliant facilities aligned with OECD, FDA, and NMPA standards
Advanced Infrastructure: SPF-grade animal housing, laminar flow labs, CT/micro-CT imaging, and automated analytics
Species Diversity: Large (NHP, dogs, minipigs) and small (mice, rats) animal models for human-relevant insights
Data-Driven Outcomes: AI-powered analytics and customizable reporting for confident decision-making
Contact us today to discuss your preclinical needs. Our team delivers tailored solutions, transparent timelines, and competitive pricing to keep your pipeline moving forward.
HuaTeng Biotechnology provides comprehensive preclinical efficacy studies to evaluate therapeutic potential, optimize drug candidates, and generate robust data packages for IND submissions. Our customized models bridge the gap between in vitro findings and clinical outcomes.
Learn MoreAt HuaTeng Biotechnology, we deliver end-to-end ADME/PK profiling services to optimize drug discovery and development, ensuring robust pharmacokinetic and safety data for small molecules, biologics, and novel modalities. Our globally compliant studies bridge preclinical and clinical phases, empowering you to prioritize candidates, mitigate attrition risks, and meet regulatory milestones.
Learn MoreHuaTeng Biotechnology provides end-to-end GLP-certified safety & toxicology studies for global clients. Expertise in small (rodent) and large animal models (NHP/canine). OECD, FDA, ICH compliant. Fast-track your drug development.
Learn MoreGlobal Compliance: AAALAC-accredited facilities with IACUC protocols aligned with EU Directive 2010/63/EU and USDA standards.
Advanced Imaging: DSA, IVUS, angiography, and micro-CT for real-time device performance tracking.
Custom Model Development: Species-specific animal models for complex disease states.
Histopathology Suite: SEM/TEM analysis with GLP-grade reporting for PMDA/CE Mark submissions.